Growth of pulmonary microvasculature in ventilated preterm infants

American Journal of Respiratory and Critical Care Medicine

Volumn 173, Issue 2, 2006, Pages 204-211

  De Paepe, Monique E ^a   Mao, Quanfu ^b   Powell, Jessica ^b   Rubin, Sam E ^b   DeKoninck, Philip ^b   Appel, Naomi ^b   Dixon, Meredith ^b   Gundogan, Füsun ^b  

^a WOMEN AND INFANTS HOSPITAL   (United States)

^b NONE

Author keywords

Bronchopulmonary dysplasia; Chronic lung disease of prematurity; Neonatal lung disease

Indexed keywords

CD31 ANTIGEN; KI 67 ANTIGEN;

ANGIOGENESIS; ARTICLE; ARTIFICIAL VENTILATION; CADAVER; CAPILLARY DENSITY; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; GESTATIONAL AGE; GROWTH DISORDER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; LUNG BLOOD VESSEL; LUNG DYSPLASIA; LUNG PARENCHYMA; LUNG VENTILATION; MALE; MICROVASCULATURE; PARENCHYMA; PREMATURITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; STEREOLOGY; WESTERN BLOTTING;

ANTIGENS, CD31; BLOTTING, WESTERN; BRONCHOPULMONARY DYSPLASIA; CELL PROLIFERATION; ENDOTHELIAL CELLS; FEMALE; GESTATIONAL AGE; HUMANS; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, VERY LOW BIRTH WEIGHT; LUNG; LUNG VOLUME MEASUREMENTS; MALE; MICROCIRCULATION; RESPIRATION, ARTIFICIAL; STILLBIRTH; TIME FACTORS;

EID: 31944447750     PISSN: 1073449X     EISSN: 1073449X     Source Type: Journal    
DOI: 10.1164/rccm.200506-927OC     Document Type: Article

References (30)

1. Jobe AH, Ikegami M. Mechanisms initiating lung injury in the preterm. Early Hum Dev 1998;53:81-94.
2. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001;163:1723-1729.
3. Lemons JA, Bauer CR, Oh W, Korones SB, Papile LA, Stoll BJ, Verter J, Temprosa M, Wright LL, Ehrenkranz RA, et al.; NICHD Neonatal Research Network. Very low birth weight outcomes of the National Institute of Child Health and Human Development Neonatal Research Network, January 1995 through December 1996. Pediatrics 2001;107:E1.
4. Erickson AM, de la Monte SM, Moore GW, Hutchins GM. The progression of morphologic changes in bronchopulmonary dysplasia. Am J Pathol 1987;127:474-484.
5. Bonikos DS, Bensch KG, Northway WH Jr, Edwards DK. Bronchopulmonary dysplasia: the pulmonary pathologic sequel of necrotizing bronchiolitis and pulmonary fibrosis. Hum Pathol 1976;7:643-666.
6. Husain AN, Siddiqui NH, Stocker JT. Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia. Hum Pathol 1998;29:710-717.
7. Jobe AJ. The new BPD: an arrest of lung development. Pediatr Res 1999;46:641-643.
8. Coalson JJ. Pathology of chronic lung disease in early infancy. In: Bland RD, Coalson JJ, editors. Chronic lung disease in early infancy. New York: Marcel Dekker; 2000. pp. 85-124.
9. Bhandari A, Bhandari V. Pathogenesis, pathology and pathophysiology of pulmonary sequelae of bronchopulmonary dysplasia in premature infants. Front Biosci 2003;8:e370-e380.
10. Bhatt AJ, Pryhuber GS, Huyck H, Watkins RH, Metlay LA, Maniscalco WM. Disrupted pulmonary vasculature and decreased vascular endothelial growth factor, Flt-1, and TIE-2 in human infants dying with bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001;164:1971-1980.
11. Coalson JJ, Winter VT, Siler-Khodr T, Yoder BA. Neonatal chronic lung disease in extremely immature baboons. Am J Respir Crit Care Med 1999;160:1333-1346.
12. Maniscalco WM, Watkins RH, Pryhuber GS, Bhatt A, Shea C, Huyck H. Angiogenic factors and alveolar vasculature: development and alterations by injury in very premature baboons. Am J Physiol Lung Cell Mol Physiol 2002;282:L811-L823.
13. Jakkula M, Le Cras TD, Gebb S, Hirth KP, Tuder RM, Voelkel NF, Abman SH. Inhibition of angiogenesis decreases alveolarization in the developing rat lung. Am J Physiol Lung Cell Mol Physiol 2000;279:L600-L607.
14. Le Cras TD, Markham NE, Tuder RM, Voelkel NF, Abman SH. Treatment of newborn rats with a VEGF receptor inhibitor causes pulmonary hypertension and abnormal lung structure. Am J Physiol Lung Cell Mol Physiol 2002;283:L555-L562.
15. Gerber HP, Hillan KJ, Ryan AM, Kowalski J, Keller GA, Rangell L, Wright BD, Radtke F, Aguet M, Ferrara N. VEGF is required for growth and survival in neonatal mice. Development 1999;126:1149-1159.
16. Galambos C, Ng YS, Ali A, Noguchi A, Lovejoy S, D'Amore PA, DeMello DE. Defective pulmonary development in the absence of heparin-binding vascular endothelial growth factor isoforms. Am J Respir Cell Mol Biol 2002;27:194-203.
17. Abman SH. Bronchopulmonary dysplasia: "a vascular hypothesis." Am J Respir Crit Care Med 2001;164:1755-1756.
18. Bolender RP, Hyde DM, Dehoff RT. Lung morphometry: a new generation of tools and experiments for organ, tissue, cell, and molecular biology. Am J Physiol 1993;265:L521-L548.
19. Gundersen HJ, Bendtsen TF, Korbo L, Marcussen N, Moller A, Nielsen K, Nyengaard JR, Pakkenberg B, Sorensen FB, Vesterby A, et al. Some new, simple and efficient stereological methods and their use in pathological research and diagnosis. APMIS 1988;96:379-394.
20. De Paepe ME. Lung growth and development. In: Churg AM, Myers JL, Tazelaar HD, Wright JL, editors. Thurlbeck's pathology of the lung. New York: Thieme Medical Publishers; 2005. pp. 39-84.
21. De Paepe ME, Mao Q, Huang C, Zhu D, Jackson CL, Hansen K. Postmortem RNA and protein stability in perinatal human lungs. Diagn Mol Pathol 2002;11:170-176.
22. Scherle W. A simple method for volumetry of organs in quantitative stereology. Mikroskopie 1970;26:57-60.
23. Weibel ER, Cruz-Orive LM. Morphometric methods. In: Crystal RG, West JB, Weibel ER, Barnes PJ, editors. The lung: scientific foundations. Philadelphia, PA: Lippincott-Raven; 1997. pp. 333-344.
24. De Paepe ME, Johnson BD, Papadakis K, Sueishi K, Luks FI. Temporal pattern of accelerated lung growth after tracheal occlusion in the fetal rabbit. Am J Pathol 1998;152:179-190.
25. De Paepe ME, Mao Q, Embree-Ku M, Rubin LP, Luks FI. Fas/FasL-mediated apoptosis in perinatal murine lungs. Am J Physiol Lung Cell Mol Physiol 2004;287:L730-L742.
26. Mitzner W, Wagner EM. Vascular remodeling in the circulations of the lung. J Appl Physiol 2004;97:1999-2004.
27. Lassus P, Turanlahti M, Heikkila P, Andersson LC,Nupponen I, Sarnesto A, Andersson S. Pulmonary vascular endothelial growth factor and Flt-1 in fetuses, in acute and chronic lung disease, and in persistent pulmonary hypertension of the newborn. Am J Respir Crit Care Med 2001;164:1981-1987.
28. Ambalavanan N, Novak ZE. Peptide growth factors in tracheal aspirates of mechanically ventilated preterm neonates. Pediatr Res 2003;53:240-244.
29. D'Angio CT, Maniscalco WM, Ryan RM, Avissar NE, Basavegowda K, Sinkin RA. Vascular endothelial growth factor in pulmonary lavage fluid from premature infants: effects of age and postnatal dexamethasone. Biol Neonate 1999;76:266-273.
30. Currie AE, Vyas JR, MacDonald J, Field D, Kotecha S. Epidermal growth factor in the lungs of infants developing chronic lung disease. Eur Respir J 2001;18:796-800.